TA
SGNT

Tamarack Advisers’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Tamarack Advisers’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-259,336
Closed -$3.88M – 46
2016
Q2 		$3.88M Buy
+259,336
New +$3.33M 1.49% 20
2016
Q1 		– Sell
-450,000
Closed -$7.16M – 35
2015
Q4 		$7.16M Buy
+450,000
New +$7.08M 0.94% 25

Tamarack Advisers's SGNT Position: Q3 2016 in Review

Tamarack Advisers sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 259,336 shares — an estimated $3.88M sold.

Tamarack Advisers first reported a position in SGNT in Q4 2015 and held it in 2 quarters. The position peaked at $7.16M in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Tamarack Advisers reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Tamarack Advisers sold 259,336 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $3.88M.
  • Tamarack Advisers first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 2 quarters.
  • Tamarack Advisers's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $7.16M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Tamarack Advisers's 13F filing for Q3 2016, filed 9 Nov 2016.